Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bellus Health Inc (BLU)

Bellus Health Inc (BLU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bellus Health Inc 275 ARMAND-FRAPPIER BLVD. LAVAL A8 H7V 4A7 CAN

www.bellushealth.com P: 45-0680-4525 F: 450-680-4501

Description:

BELLUS Health is a global health company focused on the development and commercialization of products to provide innovative health solutions to address critical unmet medical needs.

Key Statistics

Overview:

Market Capitalization, $K 1,869,209
Enterprise Value, $K 1,532,149
Shares Outstanding, K 126,812
Annual Sales, $ 20 K
Annual Net Income, $ -76,080 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -25,060 K
60-Month Beta 0.19
% of Insider Shareholders 24.17%
% of Institutional Shareholders 90.37%
Float, K 96,162
% Float 75.83%
Short Volume Ratio 0.18

Growth:

1-Year Return 57.14%
3-Year Return 22.63%
5-Year Return 852.42%
5-Year Revenue Growth -84.62%
5-Year Earnings Growth -842.86%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.20 on 05/12/23
Next Earnings Date 08/09/23
Earnings Per Share ttm -0.72
EPS Growth vs. Prev Qtr -42.86%
EPS Growth vs. Prev Year -53.85%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 5-18 on 08/19/19

BLU Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -24.27%
Return-on-Assets % -23.14%
Profit Margin % -380,400.02%
Debt/Equity 0.00
Price/Sales 116,825.55
Price/Cash Flow N/A
Price/Book 5.06
Book Value/Share 2.91
Interest Coverage -22.61
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar